Chennai, September 30, 2025 – O2D3 Physio and Fitness Solutions is proud to announce that Daranisri, a valued member of our team, has been officially granted a patent for the Spasticity Measurement Device on September 25, 2025.
This remarkable achievement highlights Daranisri’s dedication to innovation and her commitment to advancing technology in the field of physiotherapy. The patent reflects her creativity, technical expertise, and problem-solving skills, which enhance O2D3’s capabilities and contribute to better patient care.
About the Patent
The patent, titled Spasticity Measurement Device, introduces an innovative technology designed to improve clinical assessments, enhance patient outcomes, and advance rehabilitation techniques. The device provides precise, quantitative measurements of muscle spasticity, supporting therapists in delivering personalized and effective treatment plans.
Team Appreciation
The entire O2D3 team congratulates Daranisri on this outstanding accomplishment. “Securing this patent is a proud milestone for me, and I look forward to contributing further to innovative projects that make a difference,” said Daranisri.
O2D3 fosters a culture that encourages research, innovation, and professional development, and this achievement underscores the organization’s commitment to advancing healthcare solutions.
Stay Updated
Follow O2D3’s News section for more updates on our team’s achievements, patents, and innovations. For more information, visit www.o2d3.com.